Eur Rev Med Pharmacol Sci 2020; 24 (9): 5178-5179
DOI: 10.26355/eurrev_202005_21214

Editorial – High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients

C. Scoppetta, G. Di Gennaro, F. Polverino

Department of Human Physiology and Pharmacology, “Sapienza” University of Rome, Rome, Italy. cscoppetta@tin.it

Free PDF Download

To cite this article

C. Scoppetta, G. Di Gennaro, F. Polverino
Editorial – High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 9
Pages: 5178-5179
DOI: 10.26355/eurrev_202005_21214

Keywords Related articles:

  1. Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?
  2. Awake laparotomy: is locoregional anesthesia a functional option for major abdominal surgeries in the COVID-19 era?
  3. Editorial – COVID-19, more than a viral pneumonia
  4. Editorial – COVID-19 and the microbiota: new kids on the block
  5. Editorial – COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past?